Bridget E. Bunner

Array ( [id] => 1286872 [patent_doc_number] => 06635445 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-21 [patent_title] => 'Nucleic acid molecules encoding human luteinizing hormone-human chorionic gonadotropin receptor protein and transformants thereof' [patent_app_type] => B1 [patent_app_number] => 09/461657 [patent_app_country] => US [patent_app_date] => 1999-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 17903 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/635/06635445.pdf [firstpage_image] =>[orig_patent_app_number] => 09461657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1558444 [patent_doc_number] => 06436389 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Stimulation of cell proliferation by glycosylated cystatin C' [patent_app_type] => B1 [patent_app_number] => 09/459958 [patent_app_country] => US [patent_app_date] => 1999-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 18 [patent_no_of_words] => 16932 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/436/06436389.pdf [firstpage_image] =>[orig_patent_app_number] => 09459958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1354457 [patent_doc_number] => 06572851 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-06-03 [patent_title] => 'Method for suppressing or treating drug-induced nephropathy' [patent_app_type] => B2 [patent_app_number] => 09/380882 [patent_app_country] => US [patent_app_date] => 1999-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 19 [patent_no_of_words] => 4999 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/572/06572851.pdf [firstpage_image] =>[orig_patent_app_number] => 09380882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6095757 [patent_doc_number] => 20020052020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'Novel orphan receptors' [patent_app_type] => new [patent_app_number] => 09/442356 [patent_app_country] => US [patent_app_date] => 1999-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6981 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20020052020.pdf [firstpage_image] =>[orig_patent_app_number] => 09442356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1416889 [patent_doc_number] => 06514728 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Process for preparation of cytokines using Sendai virus expression system' [patent_app_type] => B1 [patent_app_number] => 09/436504 [patent_app_country] => US [patent_app_date] => 1999-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 4653 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514728.pdf [firstpage_image] =>[orig_patent_app_number] => 09436504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1602465 [patent_doc_number] => 06432643 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-13 [patent_title] => 'Method of determining Alzheimer\'s disease risk using apolipoprotein E4 genotype analysis in combination with decreased estrogen levels' [patent_app_type] => B1 [patent_app_number] => 09/425650 [patent_app_country] => US [patent_app_date] => 1999-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 3446 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/432/06432643.pdf [firstpage_image] =>[orig_patent_app_number] => 09425650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1311908 [patent_doc_number] => 06610540 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-26 [patent_title] => 'Low oxygen culturing of central nervous system progenitor cells' [patent_app_type] => B1 [patent_app_number] => 09/425462 [patent_app_country] => US [patent_app_date] => 1999-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 22 [patent_no_of_words] => 19094 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/610/06610540.pdf [firstpage_image] =>[orig_patent_app_number] => 09425462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1476676 [patent_doc_number] => 06451303 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => 'Method of treating coronary artery disease by administering a recombinant FGF' [patent_app_type] => B1 [patent_app_number] => 09/417721 [patent_app_country] => US [patent_app_date] => 1999-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 18890 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451303.pdf [firstpage_image] =>[orig_patent_app_number] => 09417721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1269639 [patent_doc_number] => 06653088 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-25 [patent_title] => 'Interaction test for the investigation of inhibitory molecules of the interaction between a presenilin and the -amyloid peptide' [patent_app_type] => B1 [patent_app_number] => 09/415099 [patent_app_country] => US [patent_app_date] => 1999-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 25 [patent_no_of_words] => 18151 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/653/06653088.pdf [firstpage_image] =>[orig_patent_app_number] => 09415099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1264018 [patent_doc_number] => 06660467 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-09 [patent_title] => 'Variant of ciliary neurotrophic factor and DNA encoding the variant' [patent_app_type] => B1 [patent_app_number] => 09/381393 [patent_app_country] => US [patent_app_date] => 1999-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 4369 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/660/06660467.pdf [firstpage_image] =>[orig_patent_app_number] => 09381393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1279899 [patent_doc_number] => 06646113 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-11 [patent_title] => 'Nucleic acid molecule encoding human survival of motor neuron-interacting protein 1 (SIP1) deletion mutants' [patent_app_type] => B1 [patent_app_number] => 09/399081 [patent_app_country] => US [patent_app_date] => 1999-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 126 [patent_no_of_words] => 68527 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/646/06646113.pdf [firstpage_image] =>[orig_patent_app_number] => 09399081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6745094 [patent_doc_number] => 20030022277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'HUMAN NEUROPEPTIDE RECEPTOR' [patent_app_type] => new [patent_app_number] => 09/393696 [patent_app_country] => US [patent_app_date] => 1999-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 103598 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022277.pdf [firstpage_image] =>[orig_patent_app_number] => 09393696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1202574 [patent_doc_number] => 06720175 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-13 [patent_title] => 'Nucleic acid molecule encoding homer 1B protein' [patent_app_type] => B1 [patent_app_number] => 09/377285 [patent_app_country] => US [patent_app_date] => 1999-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 63 [patent_no_of_words] => 75224 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/720/06720175.pdf [firstpage_image] =>[orig_patent_app_number] => 09377285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 710273 [patent_doc_number] => 07056694 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-06-06 [patent_title] => 'DNA encoding peripheral-type benzodiazipine receptor associated protein 7 and applications or methods of use' [patent_app_type] => utility [patent_app_number] => 09/762594 [patent_app_country] => US [patent_app_date] => 1999-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13751 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/056/07056694.pdf [firstpage_image] =>[orig_patent_app_number] => 09762594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 933885 [patent_doc_number] => 06977080 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-12-20 [patent_title] => 'Intrapericardial botulinum toxin treatment for bradycardia' [patent_app_type] => utility [patent_app_number] => 09/371354 [patent_app_country] => US [patent_app_date] => 1999-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9736 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/977/06977080.pdf [firstpage_image] =>[orig_patent_app_number] => 09371354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1222835 [patent_doc_number] => 06699466 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-02 [patent_title] => 'IL-16 antagonist peptides and DNA encoding the peptides' [patent_app_type] => B1 [patent_app_number] => 09/368630 [patent_app_country] => US [patent_app_date] => 1999-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 10778 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/699/06699466.pdf [firstpage_image] =>[orig_patent_app_number] => 09368630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1020854 [patent_doc_number] => 06887477 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-03 [patent_title] => 'Method of treating ischemic disease by intramuscular administration of Hepatocyte growth factor' [patent_app_type] => utility [patent_app_number] => 09/762188 [patent_app_country] => US [patent_app_date] => 1999-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 9725 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/887/06887477.pdf [firstpage_image] =>[orig_patent_app_number] => 09762188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1460577 [patent_doc_number] => 06392019 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => 'Antibodies specific for EGF motif proteins' [patent_app_type] => B1 [patent_app_number] => 09/363316 [patent_app_country] => US [patent_app_date] => 1999-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 32682 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/392/06392019.pdf [firstpage_image] =>[orig_patent_app_number] => 09363316 [rel_patent_id] =>[rel_patent_doc_number] =>)